Skip to main content
. 2021 Feb 17;13(5):6702–6711. doi: 10.18632/aging.202526

Figure 5.

Figure 5

Impact of visceral obesity on CD4+ T cells in patients with Crohn’s disease. CD patients with visceral obesity had lower level of CD4+ T cells compared with CD patients without visceral obesity (32.7 ± 3.11%, n=37 vs. 44 ± 2.65%, n=35, P < 0.001).